ImetelChat

Hello fellow board members, hope everyone is safe. Here is what we have to look forward to in the next few weeks:

1. Release of EHA abstracts, should be in first week of May

2. Results of FDA meeting, should be around mid May

3. Annual shareholders meeting June 5th

4. EHA virtual meetings second week of June.

GLTA, bp

Correction: EHA Abstract release May 14th.

What’s left of the optimism and patience I have left, is being exuded for these next 4-6 weeks.

A decade of groundbreaking preclinical work + early and mid-stage trials, which have shown an acceptable safety profile along with efficacious effects for patients, makes the path of Imetelstat primed for success in treating patients. I think it is more of a question of when rather than if for these initial heme indications of MF and MDS. That time is now or 2023.
- I’m really banking of now.

Me too, brother. As the Ram Bam said, if not now, when?